artemether-lumefantrine (ALN)
IRB00014153
Approved small_molecule completed
Quick answer
artemether-lumefantrine (ALN) for Uncomplicated Malaria is a Approved program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Uncomplicated Malaria
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed